Dayananda Sagar University M.Pharm Regulatory Affairs: Fees 2026, Course Duration, Dates, Eligibility

Ans. The M.Pharm (Regulatory Affairs) at DSU Bangalore has a total fee of INR 6,04,000 for the 2-year programme (INR 3,02,000 per year). DSU ranks 118 in Collegedunia’s 2026 Pharmacy India list. Confirm the current fee at dsu.edu.in.

Ans. B.Pharm from a PCI-recognised institution with minimum 55% aggregate is required. Admission is through Karnataka PGCET 2026, GPAT 2026, or DSAT 2026. GPAT qualifiers are given preference in the merit list.

Ans. DSU’s M.Pharm (Regulatory Affairs) covers pharmaceutical regulations, drug approval processes, regulatory submissions, clinical trial management, GMP/GLP/GCP guidelines, and international regulatory frameworks (FDA, EMA, CDSCO). Students gain knowledge of dossier preparation, post-marketing surveillance, and regulatory strategy. The programme prepares graduates for roles in drug regulatory departments at domestic and multinational pharmaceutical companies.

Ans. Graduates can work as regulatory affairs executives and managers at pharmaceutical companies, CROs, biotech firms, and regulatory consulting organisations in India and globally. Regulatory Affairs is a growing field with demand driven by increasing clinical trials and global drug filings from Indian pharma companies.

Ans. GPAT is not mandatory for M.Pharm admission at DSU. The university also accepts Karnataka PGCET 2026 and DSAT 2026. However, GPAT qualifiers are typically given priority in the merit-based selection. Apply through the channel with your best score.